Skip to content

Identification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2

DELTA-CAPNO: Identification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2 in Pre-hospital Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04489615
Acronym
DELTA-CAPNO
Enrollment
200
Registered
2020-07-28
Start date
2020-06-03
Completion date
2021-06-01
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation, Prehospital Capnography Monitoring

Keywords

capnography prehospital

Brief summary

Monocentric, prospective, observational and descriptive study on the evaluation of risk factors for alteration of the alveoarterial gradient of CO2 in pre-hospital patients, intubated and then ventilated in an invasive manner; and their impact on intra-arterial fatehospital.

Interventions

None listed

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 18 years of age, * Endotracheal intubation in pre-hospital and mechanical ventilation, * Monitoring of Etco2 in pre-hospital settings

Exclusion criteria

* Identification of a chest wound blowing during pre-hospital care, * No technical possibility for performing or analysing arterial sampling, * Death during pre-hospital care, * A person who has objected to the processing of his data for research at minimal risk and constraints (category 2) or for research on data, as well as persons subject to legal protection measures.

Design outcomes

Primary

MeasureTime frameDescription
identification of risks factors for alteration of the cellular arterial gradient of CO2 in Pre hospital patientsfrom january 2020 to april 2021The main objective is therefore to determine the main risk factors to observe an alteration of the alveoarterial gradient in CO2, at the hospital care (fixed at 10 mmHg).

Secondary

MeasureTime frameDescription
Intrahospital mortalityfrom january 2020 to april 2021prognostic evidence of altered alveocapillary gradient on intrahospital mortality
Time of hospital admissionfrom january 2020 to april 2021the prognosis of the finding of an altered alveocapillary gradient on the time of hospital admission
length of mecanical ventilationfrom january 2020 to april 2021the prognosis of the finding of an altered alveocapillary gradient on the duration of ventilation
Acute respiratory distress syndrom (ARDS)from january 2020 to april 2021the prognosis of the finding of an altered alveocapillary gradient on the occurrence of ARDS
Length of stayfrom january 2020 to april 2021the prognosis of the finding of an altered alveocapillary gradient on the length of stay
Intrahospital mortality (subpopulation of traumatized patients which had suffered from intracranial hypertensionfrom january 2020 to april 2021prognostic evidence of altered alveocapillary gradient, onset of an episode of intracranial hypertension, and intrahospital survival of severely traumatized patients (GCS \< 9).
Occurence of pneumoniafrom january 2020 to april 2021the prognosis of the finding of an altered alveocapillary gradient on the occurrence of pneumonia

Countries

France

Contacts

Primary ContactQuentin qc Carraro, md
quentin.carrar@gmail.com778817861

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026